Mod GRF 1-29 & Ipamorelin Blend
The gold standard research peptide stack: Mod GRF 1-29 (CJC-1295 no DAC) combined with ipamorelin for synergistic, selective, physiologically-patterned GH release.
Community Rating
No ratings yet
Compound Profile
Mod GRF 1-29 & Ipamorelin Blend
Key Data
Research reference only
Research Focus
Preclinical data
⚠ Research & Educational Use Only. Mod GRF 1-29 & Ipamorelin Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Considered gold standard GH research combination
- Physiological GH pulses with high selectivity (minimal cortisol/prolactin)
- 3-4x GH amplitude vs either peptide alone
- Mod GRF 1-29 & Ipamorelin Blend is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Considered gold standard GH research combination
- Physiological GH pulses with high selectivity (minimal cortisol/prolactin)
- 3-4x GH amplitude vs either peptide alone
- No motilin-related appetite stimulation (unlike GHRP-6 combinations)
In Plain English
Simple summaryMod GRF 1-29 + Ipamorelin is the 'no-DAC' version of the classic GH secretagogue combination -- Mod GRF 1-29 is the modified version of GHRH(1-29) without the Drug Affinity Complex (DAC) that gives CJC-1295 its extended half-life. Without DAC, Mod GRF 1-29 has a half-life of 15-30 minutes rather than CJC-1295's 1-2 weeks. The short half-life means Mod GRF 1-29 + Ipamorelin produces a sharper, more physiologically pulsatile GH release when injected -- mimicking the natural GH pulse pattern more closely than the sustained elevation from CJC-1295 (with DAC). Some researchers prefer the pulsatile pattern because the GH axis normally operates in discrete pulses, and sustained GH elevation may have different effects on IGF-1 regulation and receptor sensitivity.
- Considered gold standard GH research combination
- Physiological GH pulses with high selectivity
- 3-4x GH amplitude vs either peptide alone
The full scientific detail, mechanisms, citations, and dosing data, follows below.
What is Mod GRF 1-29 & Ipamorelin Blend?
Tap any underlined term for an instant definition.
The Mod GRF 1-29 & Ipamorelin Blend is considered the most selective and widely studied GH-stimulating peptide combination in the research literature. It combines the improved stability of Mod GRF 1-29 (CJC-1295 no DAC) with ipamorelin's unmatched GH selectivity among GHSPs, producing synergistic GH pulses with minimal off-target hormonal effects.
What It Is
- Mod GRF 1-29: GHRH analogue with 4-substitution DPP-IV resistance; physiological half-life preserved
- Ipamorelin: the most selective GHRP available; minimal cortisol, prolactin, or appetite effects
- The combination most frequently referenced in peer-reviewed GH secretagogue research
- Often called the "gold standard" GHRH + GHRP research stack
How It Works
- Mod GRF 1-29 activates GHRHR, producing direct somatotroph stimulation
- Ipamorelin activates GHS-R1a and suppresses hypothalamic somatostatin
- Combined GH pulse: 3-4x either peptide alone; pharmacokinetically matched (both short-acting)
- No appetite stimulation (ipamorelin lacks motilin receptor activity)
- Selectivity: cortisol and prolactin remain within normal range at standard research doses
Key Research Findings
- IGF-1 increase: 50-70% from baseline with 3 months daily twice-daily administration
- Body composition: 2-3 kg lean mass increase and 2% fat mass reduction at 6 months (research extrapolation from component studies)
- Tachyphylaxis: No significant receptor desensitization at standard doses over 6-month monitoring periods
- Comparative: Matched studies show ipamorelin produces 15% less cortisol elevation than GHRP-2 and 40% less than GHRP-6 at equivalent GH-stimulating doses
Dosing From the Literature
- Mod GRF 1-29 100-200 mcg + Ipamorelin 200-300 mcg per injection
- Twice daily: morning fasted + bedtime; or three times daily for intensive research protocols
Storage and Handling
- Lyophilised: 2-8 degrees C; 24 months
- Reconstituted: 2-8 degrees C; use within 30 days
By the Numbers
Key Research Benefits
Documented effects observed in preclinical and clinical studies on Mod GRF 1-29 & Ipamorelin Blend. See all Peptide Blends peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Subcutaneous injection on empty stomach. Best administered at bedtime and upon waking.
What the research doesn't show
The question of whether pulsatile vs sustained GH secretagogue protocols produce meaningfully different outcomes in humans is not resolved by clinical data. The physiological argument for pulsatile patterns is compelling, but whether it translates to superior body composition, recovery, or other outcomes over sustained protocols is theoretical at this stage.
Medical Expert Videos
Physicians, researchers, and pharmacologists explain Mod GRF 1-29 & Ipamorelin Blend, covering mechanisms of action, clinical context, and study findings.
Videos sourced from YouTube search. KnowYourPeptide does not endorse any individual creator. For research education only.
The Bottom Line
Mod GRF 1-29 & Ipamorelin Blend has a growing body of preclinical evidence and a well-characterised safety profile in research settings. The most-studied application is: considered gold standard gh research combination.
The most commonly reported side effect in research subjects is minimal off-target effects vs other ghrp combinations. It is a research chemical, not approved for human use.
Frequently Asked Questions
Explore Further
Quick Reference
More in Peptide Blends
- Sermorelin & Ipamorelin Blend
- Sermorelin & GHRP-2 Blend
- Sermorelin & GHRP-6 Blend
- Sermorelin & GHRP-6 & GHRP-2 Triple Blend
How It Compares
CJC-1295 (with DAC) + Ipamorelin produces similar or greater GH elevation but with sustained levels rather than discrete pulses. Sermorelin + Ipamorelin is a similar short-acting GHRH + GHRP approach. The choice between pulsatile and sustained depends on research goals: bodycomposition studies may favor sustained; physiological mimicry studies may favor pulsatile.
Compare Mod GRF 1-29 & Ipamorelin Blend side-by-sideResearch Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.